1. World Health Organization. World Health Assembly. Geneva, April 1992.
2. Drug combinations and the bioavailability of rifampicin;Fox;Tubercle,1990
3. The bioavailability of isoniazid, rifampicin and pyrazinamide in two commercially available combined formulations designed for use in the shortcourse treatment of tuberculosis;Ellard;Am Rev Respir Dis,1986
4. United States Public Health Service Tuberculosis Therapy Trial 21: preliminary results of an evaluation of a combined tablet of isoniazid. rifampin and pyrazinamide;Geiter;Tubercle,1987
5. Antituberculosis regimens of chemotherapy. Recommendations from the Committee on Treatment of the IUATLD;International Union Against Tuberculosis and Lung Disease;Bull Int Union Tuberc Lung Dis,1988